Status:

UNKNOWN

Selective Pelvic Lymphadenectomy for IB-IIA Cervical Cancer

Lead Sponsor:

Fudan University

Conditions:

Cervical Cancer

Eligibility:

FEMALE

18-70 years

Phase:

PHASE2

Brief Summary

Test name: Study on selective pelvic lymphadenectomy for IB - IIA cervical cancer Researcher: Wu Xiaohua Research Center: Fudan University Shanghai Cancer Center The trial is expected to last for 3 y...

Detailed Description

Overall objective For cervical cancer patients with confirmed lymph node metastasis by intraoperative frozen pathology, the overall treatment effect of radical hysterectomy and selective enlarged lymp...

Eligibility Criteria

Inclusion

  • histology confirmed as cervical adenocarcinoma, squamous cell carcinoma or adenosquamous carcinoma.
  • histological grading of cervical cancer is 1, 2, 3 or not.
  • patients in the group must have no reproductive function requirements.
  • Patients must be ≥ 18 years of age.
  • preoperative: pelvic CT / MR or PET / CT suggest pelvic lymph node enlargement. Intraoperative: Patients with pelvic lymph node metastasis confirmed by freezing.
  • Signed informed consent.
  • Surgery should be completed within 4 weeks after the first diagnosis.
  • patients can receive treatment and follow-up.

Exclusion

  • abdominal CT, PET / CT suggest that patients with para aortic lymph node metastasis.
  • other history of the tumor, but does not include: received appropriate treatment of non-melanoma skin cancer, has been cured of other solid tumors, has been cured or non Hodgkin's lymphoma and Hodgkin's lymphoma 5 years without recurrence.
  • Those who have received or will receive neoadjuvant chemotherapy.
  • patients with preoperative limb lymphedema or lower extremity venous and lymphatic reflux disorders.
  • pregnant women

Key Trial Info

Start Date :

September 1 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2022

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT03295526

Start Date

September 1 2017

End Date

September 1 2022

Last Update

August 19 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fudan university

Shanghai, Shanghai Municipality, China, 021